Lepu Biopharma Co., Ltd.
Clinical trials sponsored by Lepu Biopharma Co., Ltd., explained in plain language.
-
New hope for tough bladder cancer: experimental drug targets unresponsive tumors
Disease control Recruiting nowThis study tests a new drug called cretostimogene in people with a type of bladder cancer that did not get better with standard therapy (BCG). The goal is to see if the drug can make tumors disappear and keep them from coming back. About 16 adults with high-risk, non-muscle invas…
Phase: PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
New hope for advanced tumors? MRG006A trial begins
Disease control Recruiting nowThis study tests a new drug called MRG006A in people with advanced solid tumors that have not responded to other treatments. The goal is to find the safest dose and see if the drug can shrink tumors. About 343 adults aged 18 to 75 will take part in this early-phase trial across m…
Phase: PHASE1, PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:48 UTC